Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
S Petersenn, M Fleseriu, FF Casanueva… - Nature Reviews …, 2023 - nature.com
Abstract This Consensus Statement from an international, multidisciplinary workshop
sponsored by the Pituitary Society offers evidence-based graded consensus …
sponsored by the Pituitary Society offers evidence-based graded consensus …
Male infertility
A Agarwal, S Baskaran, N Parekh, CL Cho, R Henkel… - The Lancet, 2021 - thelancet.com
It is estimated that infertility affects 8–12% of couples globally, with a male factor being a
primary or contributing cause in approximately 50% of couples. Causes of male subfertility …
primary or contributing cause in approximately 50% of couples. Causes of male subfertility …
[PDF][PDF] Position statement for clinical practice: prolactin-secreting tumors
R Cozzi, MR Ambrosio, R Attanasio… - European Journal of …, 2022 - research.unipd.it
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …
clinical settings and always require an individually tailored approach. This is the reason why …
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification
In the 2022 fifth edition of the WHO Classification of Endocrine Tumours and of Central
Nervous System Tumours, pituitary adenomas are reclassified as neuroendocrine tumours …
Nervous System Tumours, pituitary adenomas are reclassified as neuroendocrine tumours …
Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges
J Martin-Grace, R Dineen, M Sherlock, CJ Thompson - Clinica chimica acta, 2020 - Elsevier
Adrenal insufficiency (AI) is a serious condition, which can arise from pathology affecting the
adrenal gland itself (primary adrenal insufficiency, PAI), hypothalamic or pituitary pathology …
adrenal gland itself (primary adrenal insufficiency, PAI), hypothalamic or pituitary pathology …
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours
J Simon, LG Perez-Rivas, Y Zhao… - European journal of …, 2023 - academic.oup.com
Objective A somatic mutational hotspot in the SF3B1 gene was reported in lactotroph
tumours. The aim of our study was to examine the prevalence of driver SF3B1 variants in a …
tumours. The aim of our study was to examine the prevalence of driver SF3B1 variants in a …
Update in pathogenesis, diagnosis, and therapy of prolactinoma
N Fukuhara, M Nishiyama, Y Iwasaki - Cancers, 2022 - mdpi.com
Simple Summary This review updates recent advances in the pathogenesis, diagnosis, and
therapy of prolactinoma. Prolactinomas, comprising 30–50% of all pituitary neuroendocrine …
therapy of prolactinoma. Prolactinomas, comprising 30–50% of all pituitary neuroendocrine …
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin …
R Cozzi, MR Ambrosio, R Attanasio… - European journal of …, 2022 - academic.oup.com
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …
clinical settings and always require an individually tailored approach. This is the reason why …
Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study
B Baussart, C Villa, A Jouinot… - European Journal of …, 2021 - academic.oup.com
Objective Microprolactinomas are currently treated with dopamine agonists. Outcome
information on microprolactinoma patients treated by surgery is limited. This study reports …
information on microprolactinoma patients treated by surgery is limited. This study reports …
Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004–2016
C Chen, Y Hu, L Lyu, S Yin, Y Yu, S Jiang, P Zhou - Scientific reports, 2021 - nature.com
Comprehensive investigations on the incidence and prognosis of pituitary tumors are still
lacking. The present study aims to summarize the incidence, demographics, and survival …
lacking. The present study aims to summarize the incidence, demographics, and survival …